The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Abstract The polymorphic microbiome is considered a new hallmark of cancer. Advances in High-Throughput Sequencing have fostered rapid developments in microbiome research. The interaction between cancer cells, immune cells, and microbiota is defined as the immuno-oncology microbiome (IOM) axis. Fung...
Saved in:
Main Authors: | Ting Ding, Chang Liu, Zhengyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-025-02227-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential
by: Ines Hadrich, et al.
Published: (2025-01-01) -
Mycobiome analyses of critically ill COVID-19 patients
by: Danielle Weaver, et al.
Published: (2025-02-01) -
Dysbiosis of the human skin mycobiome in patients receiving systemic IL-23 inhibitors
by: Yuta Koike, et al.
Published: (2025-01-01) -
Gut mycobiome alterations and network interactions with the bacteriome in patients with atherosclerotic cardiovascular disease
by: Guangming Su, et al.
Published: (2025-01-01) -
Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
by: Esen Yonca Bassoy, et al.
Published: (2025-12-01)